Dual Therapeutics
Genomic medicine for everyone
Our Vision
We develop effective, safe and affordable genomic medicine that does not integrate into the genome.
We develop technology which is widely applicable and has positive impact on humans, animals, plants and environment.
We develop sustainable and high-value products and processes.
Our Mission
We use a transient gene expression technology derived from our proprietary lipid nano particles (LNPs) loaded with multiple genetic elements designed by artificial intelligence (AI) and encoded by mRNA (messenger RNA).
We achieve more than one biological effect by sequence-specific up- and down-regulation at unprecedented precision, with superb efficiency and safety.
We apply our transformative technology to a broad range of diseases in different tissues.
Company Summary
The company is in stealth mode and funded by private investors.
We are a biopharmaceutical company located in Basel/Switzerland and focus on novel technologies and applications for genomic medicine.
We use cutting-edge technologies, derived from deep domain expertise in mRNA biology, drug delivery, drug discovery and artificial intelligence, to address and solve the greatest challenges of genomic medicine.
We perform drug discovery better, faster and cheaper than ever before.
We value diversity and inclusion with our international workforce, and we provide opportunities for personal and professional growth to our employees.
We provide significant value to our investors, coworkers and society.